Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Agape ATP Corp (ATPC)

Agape ATP to effect 1-for-50 reverse stock split effective February 9, 2026

Neutral Impact 3 of 5 shareholder Written later

Agape ATP Corporation plans a 1-for-50 reverse stock split of its common stock on February 9, 2026, with shares trading on a split-adjusted basis on the Nasdaq Capital Market from February 10, 2026. Stockholders approved an amendment at the January 30, 2026 annual meeting allowing the board to carry out reverse splits, and the board chose this ratio. The split reduces the number of outstanding shares by a factor of 50, and the authorized share count is not changed.

Key points

  • Reverse split ratio is 1-for-50, effective February 9, 2026, per the filing and press release
  • Split-adjusted trading on Nasdaq begins February 10, 2026, under the unchanged symbol ATPC
  • Common stock receives new CUSIP number 008389306; fractional shares are rounded up to the nearest whole share
  • Stock option and award terms, including exercise prices and share counts, will be adjusted proportionally

The filing

CompanyAgape ATP Corp (ATPC)
Form8-K, current report
Filed with the SECFeb 6, 2026, 11:00 AM ET
Accession number0001493152-26-005471

Items reported: 3.03 Change to Shareholder Rights5.03 Bylaw / Charter Amendment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.